These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1738264)

  • 21. Difficult intravenous access: second thoughts.
    Wax D
    Anesth Analg; 2007 Mar; 104(3):739. PubMed ID: 17312239
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous nitroglycerin for acute myocardial infarction.
    Borzak S
    Henry Ford Hosp Med J; 1991; 39(3-4):206-9. PubMed ID: 1804825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metoprolol and nitroglycerin administered intravenously in acute myocardial infarction].
    Braksator W; Kuch J; Szczepańczyk E; Mamcarz A
    Wiad Lek; 1987 Jul; 40(14):937-44. PubMed ID: 3124352
    [No Abstract]   [Full Text] [Related]  

  • 24. [Alcoholic intoxication caused by intravenous nitroglycerin: an underestimated risk?].
    Barrachina F; Mateu J; Guardiola JJ; Alonso S
    Med Clin (Barc); 1996 Apr; 106(14):555-6. PubMed ID: 8656747
    [No Abstract]   [Full Text] [Related]  

  • 25. IV nitroglycerin: reducing complications at high dosages (continuing education credit).
    Carlson S; Zell C
    Dimens Crit Care Nurs; 1988; 7(2):83-90. PubMed ID: 3128434
    [No Abstract]   [Full Text] [Related]  

  • 26. Poisonous plastics? Some cling wraps, children's toys and even IV bags may be carrying--and shedding--toxic chemicals.
    Kluger J
    Time; 1999 Mar; 153(8):53. PubMed ID: 10345921
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum nitroglycerin concentrations during extracorporeal circulation with a membrane oxygenator incorporated with a cardiopulmonary bypass circuit].
    Saitoh K; Ikeno S; Horiguchi Y; Fukuda H; Hirabayashi Y; Mitsuhata H; Akazawa S; Kasuda H; Shimizu R
    Masui; 1993 Dec; 42(12):1799-802. PubMed ID: 8301828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocolytic effects of intravenous nitroglycerin.
    de Spirlet M; Treluyer JM; Chevret S; Rey E; Tournaire M; Cabrol D; Pons G
    Fundam Clin Pharmacol; 2004 Apr; 18(2):207-13. PubMed ID: 15066136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of ethanol on the delivery of intravenous nitroglycerin solutions.
    Leor R; Feinstein M; Luria MH; Hod C; Rabinowitz B
    Eur J Clin Pharmacol; 1989; 36(3):307-10. PubMed ID: 2501101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concerns about the use of forced-air warming to facilitate intravenous cannulation: don't "hose" the patient.
    Dillon F
    Anesth Analg; 2007 Mar; 104(3):739-40; author reply 740. PubMed ID: 17312238
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of acute myocardial infarction by prolonged continuous infusion of nitroglycerin].
    Tokmachev IuK; Lazebnik LB; Gendel'man AM; Tereshchenko SN; Lesniak EA; Sheremet'ev MKh
    Sov Med; 1990; (11):59-62. PubMed ID: 2127482
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood glucose in the acute phase of myocardial infarction treated with nitroglycerin or heparin].
    Klimek K; Gregorczyk J; Olejak B; Dutkiewicz-Seredyńska G; Chełstowski K
    Przegl Lek; 1988; 45(2):269-72. PubMed ID: 3136514
    [No Abstract]   [Full Text] [Related]  

  • 36. [Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion].
    Djonlagic H; Funke K; Lessmann J; Nitsche K; Kreymann G; Lipke M; Fuchs M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():10-6. PubMed ID: 7968893
    [No Abstract]   [Full Text] [Related]  

  • 37. Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.
    Bode V; Welzel D; Franz G; Polensky U
    Arch Intern Med; 1990 Oct; 150(10):2117-9. PubMed ID: 2121114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on nitroglycerin use.
    Andrien P; Lemberg L
    Heart Lung; 1989 Jan; 18(1):100-1. PubMed ID: 2492267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does nitroglycerin show the properties of a selective venodilator?].
    Lebedinskiĭ KM; Puzanova IV; Parvanian SG; Kurapeev IS
    Anesteziol Reanimatol; 2007; (5):51-5. PubMed ID: 18051493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
    Münzel T; Kurz S; Heitzer T; Luhmann C; Just H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():38-41. PubMed ID: 7968900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.